Fractyl Health Presents New Mechanistic Data on Revita® DMR in Type 2 Diabetes
Patients treated with Revita experienced a 0.8%-point reduction in HbA1c along with a 33% improvement in markers of insulin sensitivity three months after undergoing the procedure Markers of insulin production ...